DENGVAXIA CPT Vaccine Code: 90587

Vaccine & Product Overview

HCPCS Descriptor Dengue vaccine, quadrivalent, live, 3 dose schedule, for subcutaneous use

Manufacturer Sanofi

Route of Administration Subcutaneous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Kit

About DENGVAXIA

Dengvaxia is a medication aligned to the HCPCS CPT Drug Code: 90587 for billing, pricing, and reimbursement purposes in the United States. This Vaccine medication is administered via the subcutaneous route and manufactured by Sanofi.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to 90587. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	DENGVAXIA

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

DENGVAXIA Pricing & Reimbursement

90587 Private Payer Reimbursement

$73.18 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

DENGVAXIA Vaccine Administration Codes

CPT Code	Description
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), one vaccine (single or combination vaccine/toxoid)
90472	Immunization administration (each additional vaccine or toxoid), when performed in conjunction with primary procedure.

DENGVAXIA Medically Unlikely Edits (MUE)

The most billing units of 90587 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 dose.

Practitioner Office & Hospital Outpatient

1 unit / day

Same limit in both settings

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

DENGVAXIA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Prevention of dengue disease caused by dengue virus serotypes 1–4 (in individuals with laboratory-confirmed previous dengue infection)

Frequently Asked Questions

Is there an available Dengvaxia billing and coding guide?

We have not yet identified a manufacturer source of Dengvaxia billing and coding information.

Are there any available Dengvaxia patient assistance programs?

Our team did not identify a source for Dengvaxia patient assistance information. Please reach out to our team if you feel that this is a mistake.

Where can I find Dengvaxia prescribing information?

DENGVAXIA prescribing information can be found at the link below: Visit Here →

Where can I find Dengvaxia side effect information?

Our team has not yet identified a source of side effects information for DENGVAXIA. Please check back in a few weeks.

Does billing DENGVAXIA require JZ/JW wastage modifiers?

CMS does not include DENGVAXIA (90587) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing 90587. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.